Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse
- PMID: 38571544
- PMCID: PMC10985753
- DOI: 10.5114/pg.2024.136361
Forgettable in the care of liver cirrhosis: the unseen culprits of progression from bad to worse
Abstract
Patients with liver cirrhosis constitute a critically ill and unique population, and their stability relies on a well-coordinated multidisciplinary team with a carefully structured plan. Overlooking any aspect of this plan can expedite disease progression, leading to severe complications. The lack of disease-specific nutritional guidance, the prevalent sedentary lifestyle among patients, and insufficient screening for hepatocellular carcinoma, oesophageal varices, sarcopaenia, minimal hepatic encephalopathy, and diabetes mellitus, along with fibrosis progression and cirrhosis decompensation, can add further complexities. Additionally, devaluing the impact of obesity in triggering liver cirrhosis can be disadvantageous. Prolonged and inappropriate use of proton pump inhibitors also poses a significant challenge with a wide range of complications. These often-unheeded aspects in the care of liver cirrhosis patients represents the unseen culprits of progression from bad to worse and warrant serious consideration.
Keywords: care; cirrhosis; fibrosis; liver disease; nutrition.
Copyright © 2024 Termedia.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.Aliment Pharmacol Ther. 2018 Jan;47(2):246-258. doi: 10.1111/apt.14391. Epub 2017 Nov 3. Aliment Pharmacol Ther. 2018. PMID: 29105111
-
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 1: compensated cirrhosis.Frontline Gastroenterol. 2023 Jul 28;14(6):453-461. doi: 10.1136/flgastro-2023-102430. eCollection 2023. Frontline Gastroenterol. 2023. PMID: 37862444 Free PMC article.
-
Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach.World J Gastroenterol. 2024 Mar 14;30(10):1313-1328. doi: 10.3748/wjg.v30.i10.1313. World J Gastroenterol. 2024. PMID: 38596498 Free PMC article. Review.
-
Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.Clin Orthop Relat Res. 2022 Jun 1;480(6):1077-1088. doi: 10.1097/CORR.0000000000002088. Epub 2021 Dec 31. Clin Orthop Relat Res. 2022. PMID: 34978539 Free PMC article.
-
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.Gastroenterology. 2023 Oct;165(4):1080-1088. doi: 10.1053/j.gastro.2023.06.013. Epub 2023 Aug 4. Gastroenterology. 2023. PMID: 37542503 Review.
References
-
- Kalra A, Yetiskul E, Wehrle CJ, et al. . Physiology, Liver. 2022. May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMid: . - PubMed
-
- Patel J, McClain J, Sarav M, et al. . Protein requirements for critically ill patients with renal and liver failure. Nutr Clin Pract 2017; 32: 101S-11S. - PubMed
-
- Bischoff SC, Bernal W, Dasarathy S, et al. . ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr 2020; 39: 3533-62. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials